- Home
- DNLI vs ARCB Comparison
DNLI vs ARCB Comparison
Compare DNLI & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNLI | ARCB |
|---|---|---|
| Founded | 2013 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trucking Freight/Courier Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.1B |
| IPO Year | 2017 | 1994 |
Fundamental Metrics
Financial Performance| Metric | DNLI | ARCB |
|---|---|---|
| Price | $20.47 | $129.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 12 |
| Target Price | $34.33 | ★ $122.75 |
| AVG Volume (30 Days) | ★ 1.2M | 198.5K |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 0.38% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,657,864,000.00 |
| Revenue This Year | N/A | $7.00 |
| Revenue Next Year | $408.85 | $5.80 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 12.56 |
| 52 Week Low | $12.78 | $59.43 |
| 52 Week High | $27.30 | $176.69 |
Technical Indicators
Market Signals| Indicator | DNLI | ARCB |
|---|---|---|
| Relative Strength Index (RSI) | 30.01 | 39.58 |
| Support Level | $18.86 | $115.28 |
| Resistance Level | $20.84 | $135.10 |
| Average True Range (ATR) | 0.70 | 4.81 |
| MACD | -0.25 | -0.50 |
| Stochastic Oscillator | 16.59 | 25.96 |
Price Performance
Historical ComparisonAbout DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
About ARCB ArcBest Corporation
ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.